Association Between Incretin-Based Drugs and Risk of Cholangiocarcinoma among Patients with Type 2 Diabetes: A Large Population-Based Matched Cohort Study
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY（2024）
Key words
Incretin,Glucagon-like peptide-1 receptor agonists,Cholangiocarcinoma,Dipeptidyl peptidase 4 inhibitors,Type 2 diabetes mellitus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined